Results 151 to 160 of about 35,954 (204)
Some of the next articles are maybe not open access.

CAD in Screening Mammography

American Journal of Roentgenology, 2006
The benefit and cost of computer-assisted detection (CAD) mammography screening remains a topic of great interest in breast imaging. Our purpose is to reflect on and interleave two articles in this issue of the AJR that highlight the difficulty in assessing the actual benefit of using CAD from either retrospective or prospective studies.This commentary
David, Gur, Jules H, Sumkin
openaire   +2 more sources

Screening by Mammography

JAMA, 1966
Breast cancer is the leading cause of death from cancer among women in the United States. It casts a shadow over the lives of one of every 19 women. And, despite all research and clinical efforts, there has been no significant reduction in the breast cancer death rate over the past 30 years. Efforts to find a way to reduce mortality from breast cancer
openaire   +2 more sources

Mammography in mass screening

European Journal of Cancer (1965), 1979
Abstract The statement on X-ray mammography in screening for breast cancer which was released by the National Cancer Institute in August 1976 is critically evaluated. The considerations which have led to the discontinuation of the use of mammography for screening of healthy women under 50 yr of age in the U.S. are analysed.
openaire   +3 more sources

The mathematics of screening mammography

Medical Hypotheses, 1988
In an unselected population of women in their early fifties, about 7500 mammograms would have to be performed annually at a cost of U.S. $375,000 per survivor in order to find one woman who would: 1) have an incidental cancer in stage I which was not detectable by physical examination; and 2) owe her survival to the early detection of that cancer ...
openaire   +2 more sources

Screening mammography and mortality

Medical Journal of Australia, 2003
short durations, on circumscribed populations and under tightly controlled conditions. A key, but often overlooked, issue is whether the results of studies are externally valid (generalisable). Indeed, the evidence base that dictates clinical practice and health policy should comprise data that are both internally and externally valid.
openaire   +2 more sources

‘Weighing in’ on screening mammography

Breast Cancer Research and Treatment, 2008
Obesity is associated with increased post-menopausal breast cancer risk. Overweight and obese women also tend to have a poorer prognosis when diagnosed with breast cancer compared with their matched normal weight peers. In previous studies obesity was associated with decreased utilization of screening mammography.
David, Berz   +3 more
openaire   +2 more sources

The use of screening mammography

Cancer, 1987
Screening mammography, breast x-ray examination of women without any symptoms or signs of breast cancer, is a safe and efficacious procedure. Modern mammography, which is a low-dose radiographic examination, allows safe and correct diagnosis of about 90% of the cancers.
openaire   +2 more sources

Mammography screening in Denmark.

Danish medical bulletin, 2011
Mammography screening is offered healthy women, and a high standard on professional and organizational level is mandatory not only in the screening programme but even in the diagnostic work-up and treatment. The main goal is to achieve a substantial reduction in disease specific mortality, but it is not possible to evaluate the effect on mortality ...
Vejborg, Ilse   +7 more
openaire   +3 more sources

Overdiagnosis and mammography screening

BMJ, 2009
The question is no longer whether, but how often, it occurs The NHS recently scrapped its leaflet inviting women to undergo mammography in response to criticisms that it failed to mention the major harm of screening—overdiagnosis.1 In the linked systematic review (doi:10.1136/bmj.b2587), Jorgensen and Gotzsche provide evidence that screening has led ...
openaire   +2 more sources

Controversies in Screening with Mammography

Acta Oncologica, 1997
Screening with mammography in order to detect early curable breast cancer has been widely used during the last 2-3 decades. Especially an overview of 4 randomised trials in Sweden has shown a convincing short-term relative reduction of the breast cancer mortality while the long-term absolute effect on this mortality has been impossible to study due to ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy